These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 19129484

  • 1. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
    Schmidt K, Seeger K, Scheibenbogen C, Bender R, Abdulla M, Süssmilch S, Salama A, Moldenhauer A.
    J Leukoc Biol; 2009 Mar; 85(3):563-73. PubMed ID: 19129484
    [Abstract] [Full Text] [Related]

  • 2. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
    Moldenhauer A, Frank RC, Pinilla-Ibarz J, Holland G, Boccuni P, Scheinberg DA, Salama A, Seeger K, Moore MA, Nimer SD.
    J Leukoc Biol; 2004 Sep; 76(3):623-33. PubMed ID: 15197237
    [Abstract] [Full Text] [Related]

  • 3. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia.
    Stams WA, den Boer ML, Beverloo HB, Kazemier KM, van Wering ER, Janka-Schaub GE, Pieters R.
    Haematologica; 2005 Dec; 90(12):1697-9. PubMed ID: 16330447
    [Abstract] [Full Text] [Related]

  • 4. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X, Li Q, Zhu YP, Zhou CY, Gao J, Li XH, Pan LL, Li FY, Tian X, Liu HT.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
    [Abstract] [Full Text] [Related]

  • 5. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R.
    Clin Cancer Res; 2005 Apr 15; 11(8):2974-80. PubMed ID: 15837750
    [Abstract] [Full Text] [Related]

  • 6. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.
    Tsuzuki S, Seto M, Greaves M, Enver T.
    Proc Natl Acad Sci U S A; 2004 Jun 01; 101(22):8443-8. PubMed ID: 15155899
    [Abstract] [Full Text] [Related]

  • 7. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
    Panzer-Grümayer ER, Cazzaniga G, van der Velden VH, del Giudice L, Peham M, Mann G, Eckert C, Schrauder A, Germano G, Harbott J, Basso G, Biondi A, van Dongen JJ, Gadner H, Haas OA.
    Clin Cancer Res; 2005 Nov 01; 11(21):7720-7. PubMed ID: 16278392
    [Abstract] [Full Text] [Related]

  • 8. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
    Lin PC, Chang TT, Lin SR, Chiou SS, Jang RC, Sheen JM.
    Kaohsiung J Med Sci; 2008 Jun 01; 24(6):289-96. PubMed ID: 18635414
    [Abstract] [Full Text] [Related]

  • 9. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A, Heiden T, Taube T, Körner G, Seeger K.
    Eur J Haematol; 2009 Nov 01; 83(5):420-32. PubMed ID: 19594616
    [Abstract] [Full Text] [Related]

  • 10. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
    Köhler T, Plettig R, Wetzstein W, Schmitz M, Ritter M, Mohr B, Schaekel U, Ehninger G, Bornhäuser M.
    Stem Cells; 2000 Nov 01; 18(2):139-47. PubMed ID: 10742386
    [Abstract] [Full Text] [Related]

  • 11. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
    Tiensiwakul P.
    Cancer Genet Cytogenet; 2004 Feb 01; 149(1):85-8. PubMed ID: 15104290
    [Abstract] [Full Text] [Related]

  • 12. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P, Barragán E, Verdeguer A, Cervera J, Fernández JM, Moreno I, Lerma E, Esquembre C, Tasso M, Fuster V, Bermúdez M, Sanz MA.
    Haematologica; 2002 Jan 01; 87(1):23-32. PubMed ID: 11801462
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of patients with TEL-AML1-positive acute lymphoblastic leukemia with single or multiple fusions.
    Al-Sweedan SA, Neglia JP, Steiner ME, Bostrom BC, Casey T, Hirsch BA.
    Pediatr Blood Cancer; 2007 May 01; 48(5):510-4. PubMed ID: 16763978
    [Abstract] [Full Text] [Related]

  • 14. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.
    Bernardin F, Yang Y, Cleaves R, Zahurak M, Cheng L, Civin CI, Friedman AD.
    Cancer Res; 2002 Jul 15; 62(14):3904-8. PubMed ID: 12124316
    [Abstract] [Full Text] [Related]

  • 15. Analysis of TEL proteins in human leukemias.
    Poirel H, Lacronique V, Mauchauffé M, Le Coniat M, Raffoux E, Daniel MT, Erickson P, Drabkin H, MacLeod RA, Drexler HG, Ghysdael J, Berger R, Bernard OA.
    Oncogene; 1998 Jun 04; 16(22):2895-903. PubMed ID: 9671410
    [Abstract] [Full Text] [Related]

  • 16. TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression.
    Asakura K, Uchida H, Miyachi H, Kobayashi H, Miyakawa Y, Nimer SD, Takahashi H, Ikeda Y, Kizaki M.
    Mol Cancer Res; 2004 Jun 04; 2(6):339-47. PubMed ID: 15235109
    [Abstract] [Full Text] [Related]

  • 17. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
    Seeger K, Kreuzer KA, Lass U, Taube T, Buchwald D, Eckert C, Körner G, Schmidt CA, Henze G.
    Cancer Res; 2001 Mar 15; 61(6):2517-22. PubMed ID: 11289124
    [Abstract] [Full Text] [Related]

  • 18. Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California.
    McHale CM, Wiemels JL, Zhang L, Ma X, Buffler PA, Guo W, Loh ML, Smith MT.
    Genes Chromosomes Cancer; 2003 May 15; 37(1):36-43. PubMed ID: 12661004
    [Abstract] [Full Text] [Related]

  • 19. [The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies].
    Zuna J.
    Cas Lek Cesk; 2001 Mar 15; 140(5):131-7. PubMed ID: 11347199
    [Abstract] [Full Text] [Related]

  • 20. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.
    Fischer M, Schwieger M, Horn S, Niebuhr B, Ford A, Roscher S, Bergholz U, Greaves M, Löhler J, Stocking C.
    Oncogene; 2005 Nov 17; 24(51):7579-91. PubMed ID: 16044150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.